Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
903 | 10618 | 31.7 | 69% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
499 | 19953 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | Author keyword | 554 | 84% | 3% | 298 |
2 | 5 FLUOROURACIL | Author keyword | 510 | 32% | 12% | 1325 |
3 | THYMIDINE PHOSPHORYLASE | Author keyword | 494 | 74% | 3% | 368 |
4 | S 1 | Author keyword | 322 | 55% | 4% | 407 |
5 | THYMIDYLATE SYNTHASE | Author keyword | 289 | 48% | 4% | 443 |
6 | LEUCOVORIN | Author keyword | 226 | 54% | 3% | 290 |
7 | CAPECITABINE | Author keyword | 222 | 36% | 5% | 501 |
8 | ADVANCED GASTRIC CANCER | Author keyword | 183 | 56% | 2% | 222 |
9 | OXALIPLATIN | Author keyword | 167 | 27% | 5% | 538 |
10 | IRINOTECAN | Author keyword | 136 | 25% | 4% | 466 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | 554 | 84% | 3% | 298 | Search DIHYDROPYRIMIDINE+DEHYDROGENASE | Search DIHYDROPYRIMIDINE+DEHYDROGENASE |
2 | 5 FLUOROURACIL | 510 | 32% | 12% | 1325 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
3 | THYMIDINE PHOSPHORYLASE | 494 | 74% | 3% | 368 | Search THYMIDINE+PHOSPHORYLASE | Search THYMIDINE+PHOSPHORYLASE |
4 | S 1 | 322 | 55% | 4% | 407 | Search S+1 | Search S+1 |
5 | THYMIDYLATE SYNTHASE | 289 | 48% | 4% | 443 | Search THYMIDYLATE+SYNTHASE | Search THYMIDYLATE+SYNTHASE |
6 | LEUCOVORIN | 226 | 54% | 3% | 290 | Search LEUCOVORIN | Search LEUCOVORIN |
7 | CAPECITABINE | 222 | 36% | 5% | 501 | Search CAPECITABINE | Search CAPECITABINE |
8 | ADVANCED GASTRIC CANCER | 183 | 56% | 2% | 222 | Search ADVANCED+GASTRIC+CANCER | Search ADVANCED+GASTRIC+CANCER |
9 | OXALIPLATIN | 167 | 27% | 5% | 538 | Search OXALIPLATIN | Search OXALIPLATIN |
10 | IRINOTECAN | 136 | 25% | 4% | 466 | Search IRINOTECAN | Search IRINOTECAN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FLUOROURACIL | 766 | 29% | 21% | 2271 |
2 | 5 FLUOROURACIL | 622 | 26% | 19% | 2058 |
3 | FOLINIC ACID | 456 | 46% | 7% | 731 |
4 | DIHYDROPYRIMIDINE DEHYDROGENASE | 390 | 60% | 4% | 429 |
5 | LEUCOVORIN | 362 | 30% | 10% | 1011 |
6 | BIOCHEMICAL MODULATION | 360 | 75% | 2% | 257 |
7 | HIGH DOSE LEUCOVORIN | 304 | 57% | 3% | 362 |
8 | 5 DEOXY 5 FLUOROURIDINE | 263 | 80% | 2% | 165 |
9 | DPD DEFICIENCY | 255 | 93% | 1% | 95 |
10 | ADVANCED ESOPHAGOGASTRIC CANCER | 236 | 60% | 2% | 255 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 14 | 18% | 1% | 70 |
2 | GASTRIC CANCER | 14 | 15% | 1% | 83 |
3 | GI CANCER | 2 | 13% | 0% | 13 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
5-Fluorouracil: Mechanisms of action and clinical strategies | 2003 | 1149 | 96 | 70% |
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer | 2015 | 3 | 61 | 67% |
How folate metabolism affects colorectal cancer development and treatment; a story of heterogeneity and pleiotropy | 2015 | 2 | 60 | 55% |
Current questions for the treatment of advanced gastric cancer | 2013 | 29 | 44 | 82% |
Chemotherapy for advanced gastric cancer | 2010 | 76 | 114 | 71% |
Pharmacogenomics of fluorouracil-based chemotherapy toxicity | 2015 | 1 | 72 | 88% |
5-fluorouracil induced cardiotoxicity: Review of the literature | 2012 | 26 | 42 | 93% |
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis | 2004 | 278 | 49 | 80% |
Capecitabine: A review | 2005 | 209 | 60 | 58% |
FLUOROURACIL - BIOCHEMISTRY AND PHARMACOLOGY | 1988 | 634 | 39 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOGEN BIOCHEM MED | 41 | 100% | 0.1% | 15 |
2 | CANC 2 | 19 | 74% | 0.1% | 14 |
3 | GERCOR | 15 | 77% | 0.1% | 10 |
4 | GASTROINTESTINAL ONCOL | 14 | 13% | 1.0% | 101 |
5 | EPIDEMIOL CLIN INFORMAT MANAGEMENT | 11 | 38% | 0.2% | 23 |
6 | TOKUSHIMA | 11 | 18% | 0.5% | 53 |
7 | GASTROINTESTINAL ONCOL DIGEST ENDOSCOPY | 9 | 39% | 0.2% | 19 |
8 | ONCOPHARMACOL UNIT | 9 | 29% | 0.2% | 26 |
9 | INO F | 8 | 70% | 0.1% | 7 |
10 | TOYOSU HOSP | 7 | 28% | 0.2% | 20 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018283 | CAMPTOTHECIN//SN 38//TOPOTECAN |
2 | 0.0000014647 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
3 | 0.0000013191 | FOLATE RECEPTOR//REDUCED FOLATE CARRIER//DIHYDROFOLATE REDUCTASE |
4 | 0.0000012667 | GASTRIC CANCER//GASTRECTOMY//TOTAL GASTRECTOMY |
5 | 0.0000012438 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
6 | 0.0000010219 | DEOXYCYTIDINE KINASE//PURINE NUCLEOSIDE PHOSPHORYLASE//NUCLEOSIDE TRANSPORT |
7 | 0.0000010090 | POLYNUCLEOTIDE ANALOGUE//QUIM FARMACEUT ORGAN//BENZODIOXEPINS |
8 | 0.0000009542 | RADIO FREQUENCY ABLATION//LIVER RESECTION//LIVER METASTASES |
9 | 0.0000009312 | NON SMALL CELL LUNG CANCER//XRCC1//GEFITINIB |
10 | 0.0000008708 | HAND FOOT SYNDROME//RADIATION RECALL//EXTRAVASATION |